Page last updated: 2024-09-03

mozavaptan and arginine vasopressin

mozavaptan has been researched along with arginine vasopressin in 58 studies

Compound Research Comparison

Studies (mozavaptan)	Trials (mozavaptan)	Recent Studies (post-2010) (mozavaptan)	Studies (arginine vasopressin)	Trials (arginine vasopressin)	Recent Studies (post-2010) (arginine vasopressin)
165	8	24	12,278	422	1,212

Protein Interaction Comparison

Protein	Taxonomy	mozavaptan (IC50)	arginine vasopressin (IC50)
Vasopressin V2 receptor	Homo sapiens (human)		0.242

Research

Studies (58)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	41 (70.69)	18.2507
2000's	14 (24.14)	29.6817
2010's	2 (3.45)	24.3611
2020's	1 (1.72)	2.80

Authors

Authors	Studies
Berti-Mattera, LN; Dulin, N; Mattera, R; Preston, JA; Thibonnier, M; Wilkins, PL	1
Aoyama, M; Hirano, T; Itoh, S; Kondo, K; Kotosai, K; Mori, T; Nakamura, S; Ogawa, H; Onogawa, T; Tominaga, M; Tsujimae, K; Tsujimoto, G; Yamada, Y; Yamamura, Y; Yamashita, H; Yamashita, T	1
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C	1
Adihou, H; Bonnet, D; Cottet, M; Durroux, T; Hibert, M; Kellenberger, E; Lamarque, L; Loison, S; Mouillac, B; Orcel, H; Rahmeh, R; Trinquet, E	1
Chiba, S; Tsukada, M	1
Chiba, S; Furukawa, Y; Inoue, Y; Ren, LM; Sawaki, S; Takayama, S	1
Chihara, T; Hosokawa, T; Miyamoto, H; Mori, T; Nakamura, S; Ogawa, H; Onogawa, T; Yamamura, Y; Yamashita, H; Yamashita, T	1
Kamiya, H; Matsumoto, T; Nakayama, Y; Saigo, A; Saito, R; Takano, Y; Tran, M; Yamada, K	1
Abe, Y; Aki, Y; He, H; Iwao, H; Kiyomoto, H; Tamaki, T; Yoshida, H	1
Shimizu, K	1
Asano, N; Harada, K; Hashimoto, M; Kageyama, J; Mimura, Y; Ogura, T; Oishi, T; Ota, Z; Yamauchi, T	1
Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y	1
Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y	2
Burrell, LM; Buxton, BF; Johnston, CI; Liu, JJ; Phillips, PA; Rolls, KA	1
Fujita, T; Ihara, Y; Inoue, T; Ohnishi, A; Orita, Y; Takagi, N; Tanaka, T; Toyoki, T; Yamamura, Y	1
Abe, Y; Aki, Y; Fujisawa, Y; Hayashida, Y; Kimura, S; Miyatake, A; Tamaki, T	1
Burrell, LM; Buxton, BB; Johnston, CI; Liu, JJ; Phillips, PA	1
Burrell, LM; Johnston, CI; Phillips, PA; Risvanis, J; Stephenson, JM	1
Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Saruta, T; Suzuki, H; Yamamura, Y	1
Fujihara, H; Inoue, T; Ohnishi, A; Okahara, R; Orita, Y; Tanaka, T; Yabuuchi, Y; Yamamura, Y	1
Hirai, S; Kosaka, K; Mizuno, K; Nishioka, N; Ohno, S; Osada, S; Suzuki, A	1
Bax, WA; Bos, E; Nisato, D; Saxena, PR; Stam, WB; Van der Graaf, PH	1
Abe, K; Hashimoto, J; Imai, Y; Minami, N; Munakata, M	1
Abe, K; Hashimoto, J; Imai, Y; Kim, CY; Minami, N; Munakata, M	1
Hanaoka, K; Imai, M; Kurokawa, K; Naruse, M; Yamamura, Y; Yoshitomi, K	1
Crofton, JT; Liu, H; Sato, K; Share, L; Wang, YX	1
Crofton, JT; Funyu, T; Liu, HW; Share, L; Wang, YX	1
Bankir, L; Barberis, C; Brossard, G; Chicot, D; Foulon, L; Galindo, G; Garcia, C; Garcia, G; Guillon, G; Jard, S; Lacour, C; Le Fur, G; Maffrand, JP; Marty, E; Nisato, D; Pouzet, B; Raufaste, D; Serradeil-Le Gal, C; Valette, G; Vilain, P	1
Calò, G; Regoli, D; Rizzi, A; Traina, L	1
Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A	1
Abe, K; Ishikawa, S; Kamoi, K; Saito, T; Saruta, T; Shimizu, K; Yamada, K; Yoshida, S	1
Aldred, KL; Burrell, LM; Johnston, CI; Naitoh, M; Phillips, PA; Risvanis, J; Rockell, MD	1
Ishikawa, S; Saito, T	2
Kim, JK; Martin, PY; Ohara, M; Pattison, TA; Schrier, RW; St John, J; Xu, DL	1
Chau, T; Inoue, T; Kawai, B; Koizumi, F; Kunihiro, N; Matsuo, A; Ohnishi, A; Okada, K; Tada, Y; Tanaka, T; Yamamura, Y	1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Aldred, KL; Burrell, LM; Chan, RK; Johnston, CI; Phillips, PA; Risvanis, J	1
Ciarkowski, J; Czaplewski, C; Kaźmierkiewicz, R	1
Bandoh, T; Dolgor, B; Kitano, S; Matsumoto, T; Ninomiya, K; Yoshida, T	1
Akaike, N; Nabekura, J; Omura, T	1
Aukland, K; Roald, AB; Tenstad, O	1
Lankhuizen, IM; Saxena, PR; Schoemaker, RG; van Veghel, R	1
Ishiguro, S; Iwasaki, T; Miyamoto, A; Mori, T; Nishio, A	1
Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H	1
Arima, H; Hirabayashi, M; Miura, Y; Murase, T; Nagasaki, H; Oiso, Y; Tachikawa, K; Yokoi, H	1
Murakami, Y; Nakamura, K; Okada, S; Yokotani, K	1
Abe, K; Egashira, N; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Miura, I; Tsukikawa, H	1
Ishikawa, SE; Sasaki, M	1
Farkas, J; Janáky, T; László, F; László, FA; Molnár, AH; Tóth, G; Varga, C	1
Cowley, AW; O'Connor, PM	1
Torres, VE	1
Berkó, A; László, F; László, FA; Molnár, AH; Párducz, A; Rojik, I; Varga, C	1
Doi, K; Kakigi, A; Nishimura, M; Okada, T; Takeda, T	1
Iwao, H; Izumi, Y; Miura, K	1
Gui, YH; Jiang, ZL; Li, X; Liu, GZ; Liu, HX; Peng, B; Qiu, WX; Wang, GH; Wang, JX; Xiao, SF; Xu, LH; Yang, Y; Zhao, CC; Zhou, X	1

Reviews

4 review(s) available for mozavaptan and arginine vasopressin

Article	Year
[Disorders of body water regulation and the therapy--vasopressin antagonists]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines	1997
[Renal action of vasopressin]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Drug Design; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mutation; Piperidines; Quinolones; Receptors, Vasopressin	2006
Role of vasopressin antagonists. Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:4 Topics: Adolescent; Adult; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Fluids; Cell Proliferation; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Kidney; Male; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Tolvaptan; Treatment Outcome	2008
Therapeutic potential of vasopressin-receptor antagonists in heart failure. Journal of pharmacological sciences, 2014, Volume: 124, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling	2014

Trials

4 trial(s) available for mozavaptan and arginine vasopressin

Article	Year
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans. Kidney international, 1995, Volume: 48, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation	1995
Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2 Topics: Administration, Oral; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dose-Response Relationship, Drug; Hemodynamics; Humans; Male; Osmolar Concentration	1995
Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:4 Topics: Aged; Arginine Vasopressin; Benzazepines; Diuresis; Diuretics; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Osmolar Concentration; Sodium; Treatment Outcome; Urine	1997
Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis. Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:5 Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Dinoprostone; Diuresis; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration	1998

Other Studies

50 other study(ies) available for mozavaptan and arginine vasopressin

Article	Year
The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways. Endocrinology, 1997, Volume: 138, Issue:10 Topics: Animals; Arachidonic Acid; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CHO Cells; Cricetinae; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Female; Humans; Ligands; Pertussis Toxin; Phenotype; Phosphorylation; Pituitary Gland; Protein Binding; Protein Kinase C; Receptors, Vasopressin; Signal Transduction; Thymidine; Tritium; Type C Phospholipases; Virulence Factors, Bordetella	1997
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Creatinine; Diuretics; Dose-Response Relationship, Drug; HeLa Cells; Humans; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium; Tolvaptan; Transfection	1998
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. British journal of pharmacology, 1998, Volume: 125, Issue:7 Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium	1998
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463. Kidney international, 2000, Volume: 58, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance	2000
Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR: application to ligand screening and oligomerization assays. Journal of medicinal chemistry, 2012, Oct-25, Volume: 55, Issue:20 Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Click Chemistry; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; High-Throughput Screening Assays; Ligands; Models, Molecular; Protein Multimerization; Receptors, Oxytocin; Receptors, Vasopressin; Solubility; Structure-Activity Relationship	2012
Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries. European journal of pharmacology, 1992, Oct-20, Volume: 221, Issue:2-3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Female; Femoral Artery; In Vitro Techniques; Macaca; Male; Norepinephrine; Piperidines; Quinolones; Vasoconstriction	1992
Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Dogs; Heart; Heart Atria; Perfusion; Piperidines; Quinolones; Receptors, Vasopressin	1992
Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. British journal of pharmacology, 1992, Volume: 105, Issue:4 Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzazepines; Binding, Competitive; Cell Membrane; Diuresis; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Kidney; Liver; Male; Natriuresis; Rats; Receptors, Angiotensin; Receptors, Vasopressin	1992
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats. Neuroscience letters, 1993, Sep-03, Volume: 159, Issue:1-2 Topics: Animals; Arginine Vasopressin; Benzazepines; Diuresis; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Urodynamics; Water	1993
Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation. Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:2 Topics: Animals; Arginine; Arginine Vasopressin; Benzazepines; Blood Pressure; Dogs; Female; Male; Nitric Oxide; Nitroarginine; Receptors, Vasopressin; Renal Circulation; Vascular Resistance; Vasodilation	1994
Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors. Acta medica Okayama, 1995, Volume: 49, Issue:1 Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Heart Rate; Hypertension; Male; Piperidines; Quinolones; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Vasopressin; Stimulation, Chemical	1995
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. The American journal of physiology, 1994, Volume: 267, Issue:6 Pt 2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium	1994
In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats. The Journal of endocrinology, 1994, Volume: 143, Issue:2 Topics: Animals; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Diuresis; Male; Osmolar Concentration; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Water Deprivation	1994
Vascular responses to vasopressin antagonists in man and rat. Clinical science (London, England : 1979), 1994, Volume: 87, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Culture Techniques; Dose-Response Relationship, Drug; Female; Humans; Mammary Arteries; Mesenteric Artery, Superior; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Species Specificity; Vasoconstriction	1994
Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Kidney international, 1994, Volume: 46, Issue:1 Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Liver Cirrhosis, Experimental; Male; Osmolar Concentration; Rats; Rats, Wistar; Vasopressins; Water-Electrolyte Balance	1994
Role of vasopressin on cardiovascular changes during hemorrhage in conscious rats. The American journal of physiology, 1994, Volume: 267, Issue:5 Pt 2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Heart Rate; Hemorrhage; In Vitro Techniques; Kidney; Male; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Renal Artery; Sympathetic Nervous System; Time Factors	1994
Human internal mammary artery responses to non-peptide vasopressin antagonists. Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Breast; Female; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Piperidines; Quinolones; Receptors, Vasopressin; Regional Blood Flow	1994
Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260). Blood pressure, 1994, Volume: 3, Issue:1-2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Dose-Response Relationship, Drug; Kidney Medulla; Liver; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin	1994
Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs. The American journal of physiology, 1993, Volume: 265, Issue:4 Pt 2 Topics: Animals; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Diuresis; Dogs; Drug Combinations; Hemodynamics; Male; Natriuresis; Osmolar Concentration; Piperidines; Quinolones; Receptors, Vasopressin; Renal Circulation; Vasodilation	1993
Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. The Journal of clinical investigation, 1993, Volume: 92, Issue:6 Topics: Adult; Aldosterone; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Chlorides; Diuresis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Rate; Humans; Male; Osmolar Concentration; Potassium; Renin; Sodium; Time Factors; Urine	1993
Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation. FEBS letters, 1995, Dec-27, Volume: 377, Issue:3 Topics: Androstadienes; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Piperidines; Quinolones; Rats; Receptors, Vasopressin; Signal Transduction; Tetradecanoylphorbol Acetate; Wortmannin	1995
[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists. European journal of pharmacology, 1995, Oct-16, Volume: 285, Issue:2 Topics: Adolescent; Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Child; Coronary Vessels; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Muscle, Smooth, Vascular; Piperidines; Potassium; Pyrrolidines; Quinolones; Vasoconstrictor Agents	1995
Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats. Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:4 Topics: Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Blood Pressure Determination; Diuresis; Hypertension; Male; Piperidines; Quinolones; Rats; Sodium Chloride	1995
Role of vasopressin in neurocardiogenic responses to hemorrhage in conscious rats. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:1 Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Autonomic Nerve Block; Benzazepines; Cardiovascular System; Deamino Arginine Vasopressin; Diabetes Insipidus; Heart; Hemorrhage; Male; Nervous System; Rats; Rats, Brattleboro; Rats, Inbred Strains; Receptors, Vasopressin; Recurrence; Vasopressins	1996
Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct. Kidney international. Supplement, 1996, Volume: 55 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Cyclic AMP; Electrophysiology; In Vitro Techniques; Kidney Cortex; Kidney Tubules, Collecting; Male; Membrane Potentials; Patch-Clamp Techniques; Piperidines; Quinolones; Rabbits; Receptors, Vasopressin; Renal Agents; Sodium	1996
V2-receptor blockade enhances pressor response to vasopressin: gender difference. Life sciences, 1996, Volume: 59, Issue:8 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Estrus; Female; Heart Rate; Male; Rats; Rats, Sprague-Dawley; Sex Characteristics; Time Factors	1996
Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats. Brain research, 1996, May-06, Volume: 719, Issue:1-2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Drug Evaluation, Preclinical; Feedback; Female; Hormone Antagonists; Injections, Intraventricular; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sex Characteristics; Sodium Chloride; Vasopressins	1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. The Journal of clinical investigation, 1996, Dec-15, Volume: 98, Issue:12 Topics: Adenylyl Cyclases; Administration, Oral; Adrenal Glands; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Autoradiography; Benzazepines; Binding, Competitive; Furosemide; Hydrochlorothiazide; Kidney; Molecular Structure; Morpholines; Potassium; Rats; Sodium; Spiro Compounds; Urine	1996
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery. Life sciences, 1997, Volume: 60, Issue:4-5 Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Arteries; Benzazepines; Humans; In Vitro Techniques; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxytocin; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Stomach; Vasoconstrictor Agents	1997
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents	1997
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR. The American journal of physiology, 1997, Volume: 272, Issue:2 Pt 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Hypertension; Male; Myocardium; Organ Size; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Systole; Time Factors	1997
Upregulation of aquaporin 2 water channel expression in pregnant rats. The Journal of clinical investigation, 1998, Mar-01, Volume: 101, Issue:5 Topics: Actins; Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Benzazepines; Blotting, Northern; Blotting, Western; Female; Fluorescent Antibody Technique, Indirect; Gene Expression; Immunohistochemistry; Ion Channels; Kidney; Osmolar Concentration; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium; Up-Regulation; Vasopressins; Water	1998
Therapeutic efficacy of vasopressin receptor antagonists. Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuresis; Edema; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Rats	1998
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovascular research, 1998, Volume: 38, Issue:1 Topics: Analysis of Variance; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Leucine; Myocardium; Piperidines; Protein Biosynthesis; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Stimulation, Chemical; Thymidine	1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. The American journal of physiology, 1998, Volume: 275, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Female; Heart; Heart Failure; Hemodynamics; Lung; Myocardial Infarction; Organ Size; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Survival Analysis; Systole	1998
Molecular modelling of the vasopressin V2 receptor/antagonist interactions. Acta biochimica Polonica, 1998, Volume: 45, Issue:1 Topics: Amino Acid Sequence; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Kidney; Models, Molecular; Molecular Sequence Data; Receptors, Vasopressin	1998
Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum. The Journal of surgical research, 1998, Volume: 79, Issue:2 Topics: Animals; Arginine Vasopressin; Benzazepines; Diuresis; Glomerular Filtration Rate; Kidney; Male; Pneumoperitoneum; Rats; Rats, Sprague-Dawley; Vasopressins	1998
Intracellular pathways of V(1) and V(2) receptors activated by arginine vasopressin in rat hippocampal neurons. The Journal of biological chemistry, 1999, Nov-12, Volume: 274, Issue:46 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Cyclic AMP-Dependent Protein Kinases; Deamino Arginine Vasopressin; Egtazic Acid; Enzyme Inhibitors; Glycine; Hippocampus; Neurons; Oligopeptides; Patch-Clamp Techniques; Peptide Fragments; Protein Kinase C; Pyrrolidonecarboxylic Acid; Rats; Receptors, Vasopressin	1999
The effect of AVP-V2 receptor stimulation on local GFR in the rat kidney. Acta physiologica Scandinavica, 2000, Volume: 168, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Diuresis; Female; Glomerular Filtration Rate; Kidney Cortex; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin	2000
[Arg8]-vasopressin-induced responses on coronary and mesenteric arteries of rats with myocardial infarction: the effects of V1a- and V2-receptor antagonists. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Coronary Circulation; Coronary Vessels; Indoles; Ligation; Male; Mesenteric Arteries; Myocardial Infarction; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Vasoconstrictor Agents	2000
Vasopressin receptor subtypes on mesenteric and cremasteric arterioles in rat. European journal of pharmacology, 2000, Jul-14, Volume: 400, Issue:1 Topics: Animals; Arginine Vasopressin; Arterioles; Benzazepines; Male; Mesenteric Arteries; Muscle, Skeletal; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Vasoconstriction	2000
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. European journal of pharmacology, 2001, Sep-07, Volume: 427, Issue:1 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine	2001
Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene. The Journal of endocrinology, 2002, Volume: 173, Issue:1 Topics: Adaptation, Physiological; Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blotting, Northern; Body Water; Homeostasis; Humans; Kidney; Male; Metallothionein; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Recombinant Fusion Proteins; RNA, Messenger; Sodium; Zinc	2002
Vasopressin V(1) receptor-mediated activation of central sympatho-adrenomedullary outflow in rats. European journal of pharmacology, 2002, Dec-13, Volume: 457, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epinephrine; Indomethacin; Male; Norepinephrine; Rats; Rats, Wistar; Receptors, Vasopressin; Time Factors; Vasopressins	2002
Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology, 2003, Volume: 44, Issue:4 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine	2003
Biological half-life and organ distribution of [3H]8-arginine vasopressin following administration of vasopressin receptor antagonist OPC-31260. Regulatory peptides, 2007, Jun-07, Volume: 141, Issue:1-3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Half-Life; Kidney; Male; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Wistar; Tissue Distribution; Tritium	2007
Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Transporting ATPases; Cyclic AMP-Dependent Protein Kinases; Kidney Medulla; Kidney Tubules, Collecting; Male; Nitric Oxide; Phosphatidylinositols; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Signal Transduction; Spectrometry, Fluorescence; Type C Phospholipases; Vasopressins	2007
Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260. Progress in brain research, 2008, Volume: 170 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Water; Brain; Brain Edema; Carotid Arteries; Disease Models, Animal; Electrolytes; Humans; Hypoxia, Brain; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Survival Rate	2008
Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist. Acta oto-laryngologica, 2009, Volume: 129, Issue:7 Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Endolymphatic Hydrops; Injections, Subcutaneous; Meniere Disease; Microscopy, Electron, Transmission; Premedication; Rats; Stria Vascularis	2009
Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness. The Journal of pharmacology and experimental therapeutics, 2020, Volume: 373, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Dogs; Ear, Inner; Female; Male; Motion Sickness; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Signal Transduction	2020